Terms: = Breast cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132
92 results:
1. breast cancer cells have an increased ferroptosis risk induced by system x
Xue W; Yu Y; Yao Y; Zhou L; Huang Y; Wang Y; Chen Z; Wang L; Li X; Wang X; Du R; Shen Y; Xu Q
Redox Biol; 2024 Apr; 70():103034. PubMed ID: 38211443
[TBL] [Abstract] [Full Text] [Related]
2. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
3. Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel.
Yan K; Niu L; Wu B; He C; Deng L; Chen C; Lan Z; Lin C; Kuang W; Lin H; Zou J; Zhang W; Luo Z
Ann Med; 2023; 55(2):2280708. PubMed ID: 37967237
[TBL] [Abstract] [Full Text] [Related]
4. Wogonin Diminishes Radioresistance of breast cancer via Inhibition of the Nrf2/HIF-1[Formula: see text] Pathway.
Wang T; Wang P; Wang S; Ma Y; Zhao Z; Long F
Am J Chin Med; 2023; 51(8):2243-2262. PubMed ID: 37903716
[TBL] [Abstract] [Full Text] [Related]
5. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer.
Xia L; Ma W; Afrashteh A; Sajadi MA; Fakheri H; Valilo M
Biochem Med (Zagreb); 2023 Oct; 33(3):030504. PubMed ID: 37841775
[TBL] [Abstract] [Full Text] [Related]
6. The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer.
Wang S; Wang Y; Li Q; Li X; Feng X; Zeng K
Redox Biol; 2023 Nov; 67():102896. PubMed ID: 37783059
[TBL] [Abstract] [Full Text] [Related]
7. Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
Boyraz B; Sgroi DC; Iafrate AJ; Lerwill MF
Histopathology; 2023 Dec; 83(6):989-993. PubMed ID: 37771083
[TBL] [Abstract] [Full Text] [Related]
8. TMED2 Induces Cisplatin Resistance in breast cancer via Targeting the keap1-Nrf2 Pathway.
Liang C; Zhang HY; Wang YQ; Yang LA; Du YS; Luo Y; Zhang TC; Xu Y
Curr Med Sci; 2023 Oct; 43(5):1023-1032. PubMed ID: 37615927
[TBL] [Abstract] [Full Text] [Related]
9. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating keap1 and inhibiting ferroptosis.
Wang Z; Li R; Hou N; Zhang J; Wang T; Fan P; Ji C; Zhang B; Liu L; Wang Y; Kong J; Yao Q; Duan J; Zhao G; Ling R; Zhang J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37380368
[TBL] [Abstract] [Full Text] [Related]
10. Potential inhibitors of RPS6KB2 and NRF2 in head and neck squamous cell carcinoma.
Madhukar G; Subbarao N
J Biomol Struct Dyn; 2024; 42(4):1875-1900. PubMed ID: 37160694
[TBL] [Abstract] [Full Text] [Related]
11. Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.
Yu W; Chen Y; Putluri N; Osman A; Coarfa C; Putluri V; Kamal AHM; Asmussen JK; Katsonis P; Myers JN; Lai SY; Lu W; Stephan CC; Powell RT; Johnson FM; Skinner HD; Kazi J; Ahmed KM; Hu L; Threet A; Meyer MD; Bankson JA; Wang T; Davis J; Parker KR; Harris MA; Baek ML; Echeverria GV; Qi X; Wang J; Frederick AI; Walsh AJ; Lichtarge O; Frederick MJ; Sandulache VC
Br J Cancer; 2023 Jun; 128(11):2013-2024. PubMed ID: 37012319
[TBL] [Abstract] [Full Text] [Related]
12. Inhibitors of keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer.
Xie T; Zahid H; Ali AR; Joyce R; Yang G; Winz C; Le Y; Zhou R; Furmanski P; Hu L; Suh N
Toxicol Appl Pharmacol; 2023 Feb; 460():116375. PubMed ID: 36634873
[TBL] [Abstract] [Full Text] [Related]
13. Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells.
Matsunaga T; Horinouchi M; Saito H; Hisamatsu A; Iguchi K; Yoshino Y; Endo S; Ikari A
J Biochem; 2023 Mar; 173(3):167-175. PubMed ID: 36413758
[TBL] [Abstract] [Full Text] [Related]
14. Alloimperatorin activates apoptosis, ferroptosis, and oxeiptosis to inhibit the growth and invasion of breast cancer cells in vitro.
Zhang J; Gao RF; Li J; Yu KD; Bi KX
Biochem Cell Biol; 2022 Jun; 100(3):213-222. PubMed ID: 35263194
[TBL] [Abstract] [Full Text] [Related]
15. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
16. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract] [Full Text] [Related]
17. Harnessing the E3 Ligase keap1 for Targeted Protein Degradation.
Wei J; Meng F; Park KS; Yim H; Velez J; Kumar P; Wang L; Xie L; Chen H; Shen Y; Teichman E; Li D; Wang GG; Chen X; Kaniskan HÜ; Jin J
J Am Chem Soc; 2021 Sep; 143(37):15073-15083. PubMed ID: 34520194
[TBL] [Abstract] [Full Text] [Related]
18. TP53 Null Mutations Identify Lung cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin.
Hinz TK; Kalkur R; Rabinovitch J; Hinkle W; Heasley LE
Mol Pharmacol; 2021 Aug; 100(2):144-154. PubMed ID: 34031188
[TBL] [Abstract] [Full Text] [Related]
19. Exome of Radiation-induced Rat Mammary Carcinoma Shows Copy-number Losses and Mutations in Human-relevant cancer Genes.
Moriyama H; Daino K; Ishikawa A; Imaoka T; Nishimura M; Nishimura Y; Takabatake M; Morioka T; Inoue K; Fukushi M; Shimada Y; Kakinuma S
Anticancer Res; 2021 Jan; 41(1):55-70. PubMed ID: 33419799
[TBL] [Abstract] [Full Text] [Related]
20. keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in breast cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract] [Full Text] [Related]
[Next]
